基于纳米颗粒克服多药耐药性的药物递送系统研究进展

[Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].

作者信息

Chen Jia-nian, Shen Qi, Li Shao-shun

机构信息

School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China.

出版信息

Yao Xue Xue Bao. 2009 Apr;44(4):333-7.

DOI:
Abstract

Multi-drug resistance (MDR) of cancer cells is a major cause of failure in chemotherapy. To the majority of anti-cancer drugs, tumor cells are able to generate a multi-drug resistance; but there is no common views on the mechanism of MDR. This review summarizes the use of drug delivery system based on nanoparticles to overcome MDR in recent years. Three kinds including non-modified, ligand-modified and multifunctional drug delivery systems are described. Especially, the mechanism of reversing MDR based on nanoparticles is covered. Through efficiently offsetting and antagonizing the action of pumping drugs out of the tumor cells, drug delivery system based on nanoparticles can increase the concentration of the drug in tumors, while reduce the side effects on normal cells and overcome multi-drug resistance. The use of drug-loaded nanoparticles, which combines nanotechnology with the strategy of active and passive targeting administration, has shown significant prospect improving cancer therapy.

摘要

癌细胞的多药耐药性(MDR)是化疗失败的主要原因。对于大多数抗癌药物,肿瘤细胞都能够产生多药耐药性;但关于多药耐药性的机制尚无统一观点。本综述总结了近年来基于纳米颗粒的药物递送系统用于克服多药耐药性的情况。描述了包括未修饰、配体修饰和多功能药物递送系统在内的三种类型。特别涵盖了基于纳米颗粒逆转多药耐药性的机制。基于纳米颗粒的药物递送系统通过有效抵消和拮抗将药物泵出肿瘤细胞的作用,可提高肿瘤内药物浓度,同时降低对正常细胞的副作用并克服多药耐药性。负载药物的纳米颗粒的应用将纳米技术与主动和被动靶向给药策略相结合,在改善癌症治疗方面已显示出显著前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索